Lv21
138 积分 2024-07-30 加入
The present and future of bispecific antibodies for cancer therapy
6小时前
已完结
Development of bispecific antibodies in China: overview and prospects
6小时前
已完结
Bioassay Development for Bispecific Antibodies-Challenges and Opportunities
6小时前
已完结
Development challenges of high concentration monoclonal antibody formulations
2个月前
已完结
Challenges in the development of high protein concentration formulations
2个月前
已完结
Protein–Protein Interactions of Highly Concentrated Monoclonal Antibody Solutions via Static Light Scattering and Influence on the Viscosity
2个月前
已完结
Deconvoluting Biophysical Factors that Influence Long-Term Aggregation Rates of High-Concentration Monoclonal Antibody Formulations
3个月前
已完结
Understanding and controlling the molecular mechanisms of protein aggregation in mAb therapeutics
3个月前
已完结
Comparability strategy and demonstration for post-approval production cell line change of a bevacizumab biosimilar IBI305
3个月前
已完结
Forced degradation of recombinant monoclonal antibodies: A practical guide
4个月前
已完结
皖公网安备34019202002308
